Mid-Florida Hematology Oncology — Orange City, Florida

Mid-Florida Hematology Oncology is a clinical research site located in Orange City, Florida, United States 55905.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Mid-Florida Hematology Oncology has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Limited-stage Small Cell Lung Cancer (LS-SCLC), Metastatic Non-Small Cell Lung Cancer, NSCLC.

Sponsors: Shanghai Junshi Bioscience Co., Ltd., G1 Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Florida Hematology Oncology?

Mid-Florida Hematology Oncology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Florida Hematology Oncology conducted?

Mid-Florida Hematology Oncology has 2 clinical trials on record, with 1 currently active. Their work covers Limited-stage Small Cell Lung Cancer (LS-SCLC), Metastatic Non-Small Cell Lung Cancer, NSCLC.

Is Mid-Florida Hematology Oncology accredited by Crixeo Health?

Mid-Florida Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Florida Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.